Literature DB >> 24370948

Survival benefit of lateral lymph node dissection according to the region of involvement and the number of lateral lymph nodes involved.

Shozo Yokoyama1, Katsunari Takifuji, Tsukasa Hotta, Kenji Matsuda, Takashi Watanabe, Yasuyuki Mitani, Junji Ieda, Hiroki Yamaue.   

Abstract

PURPOSE: The effectiveness of lateral lymph node dissection for extending the survival of patients with advanced lower rectal cancer remains unclear. The purpose of this study was to clarify the survival benefit of lateral lymph node dissection according to the region of involvement and the number of lateral lymph nodes involved.
METHODS: We reviewed 131 consecutive patients with advanced lower rectal cancer, who had undergone curative resection with total mesorectal excision plus extended lateral lymph node dissection at Wakayama Medical University Hospital. Twenty-six (19.1 %) of these patients had lateral lymph involvement. We performed univariate and multivariate analyses for the 3-year disease-free and overall survival of these patients.
RESULTS: Multivariate analysis revealed that the number (>1) and the region (common iliac artery region or external iliac artery region) of lateral lymph node metastasis are independent predictive factors for recurrence and survival. The Kaplan-Meier analysis demonstrated that patients with one lymph node metastasis in the internal iliac artery or obturator region had better survival.
CONCLUSIONS: Lateral lymph node dissection resulted in survival benefit for patients with single lateral lymph node involvement in the internal iliac artery region or the obturator region.

Entities:  

Mesh:

Year:  2013        PMID: 24370948     DOI: 10.1007/s00595-013-0815-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  26 in total

1.  Local recurrence following total mesorectal excision for rectal cancer.

Authors:  G Arbman; E Nilsson; O Hallböök; R Sjödahl
Journal:  Br J Surg       Date:  1996-03       Impact factor: 6.939

2.  Indication and benefit of pelvic sidewall dissection for rectal cancer.

Authors:  Kenichi Sugihara; Hirotoshi Kobayashi; Tomoyuki Kato; Takeo Mori; Hidetaka Mochizuki; Shingo Kameoka; Kazuo Shirouzu; Tetsuichiro Muto
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

3.  Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.

Authors:  M Ueno; M Oya; K Azekura; T Yamaguchi; T Muto
Journal:  Br J Surg       Date:  2005-06       Impact factor: 6.939

4.  Prognostic determinants of patients with lateral nodal involvement by rectal cancer.

Authors:  H Ueno; H Mochizuki; Y Hashiguchi; K Hase
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

5.  Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project.

Authors:  A L Martling; T Holm; L E Rutqvist; B J Moran; R J Heald; B Cedemark
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

6.  Total mesorectal excision in the operative treatment of carcinoma of the rectum.

Authors:  W E Enker; H T Thaler; M L Cranor; T Polyak
Journal:  J Am Coll Surg       Date:  1995-10       Impact factor: 6.113

7.  Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.

Authors:  Hirotoshi Kobayashi; Hidetaka Mochizuki; Tomoyuki Kato; Takeo Mori; Shingo Kameoka; Kazuo Shirouzu; Kenichi Sugihara
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  Mesorectal excision for rectal cancer.

Authors:  R J Aitken
Journal:  Br J Surg       Date:  1996-02       Impact factor: 6.939

10.  Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection.

Authors:  T Mori; K Takahashi; M Yasuno
Journal:  Langenbecks Arch Surg       Date:  1998-12       Impact factor: 3.445

View more
  9 in total

1.  Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.

Authors:  Atsushi Ogura; Tsuyoshi Konishi; Geerard L Beets; Chris Cunningham; Julio Garcia-Aguilar; Henrik Iversen; Shigeo Toda; In Kyu Lee; Hong Xiang Lee; Keisuke Uehara; Peter Lee; Hein Putter; Cornelis J H van de Velde; Harm J T Rutten; Jurriaan B Tuynman; Miranda Kusters
Journal:  JAMA Surg       Date:  2019-09-18       Impact factor: 14.766

2.  Study of therapeutic results, lymph node ratio, short-term and long-term complications of lateral lymph node dissection in rectal cancer patients.

Authors:  Habibollah Mahmoodzadeh; Ramesh Omranipour; Anahita Borjian; Mohammad Amin Borjian
Journal:  Turk J Surg       Date:  2020-06-08

3.  Sentinel Lymph Node Analysis in Colorectal Cancer Patients Using One-Step Nucleic Acid Amplification in Combination With Fluorescence and Indocyanine Green.

Authors:  Francesco Esposito; Adele Noviello; Nicola Moles; Enrico Coppola Bottazzi; Mario Baiamonte; Ina Macaione; Umberto Ferbo; Maria Lepore; Antonio Miro; Francesco Crafa
Journal:  Ann Coloproctol       Date:  2019-08-31

Review 4.  Prevalence of Metastatic Lateral Lymph Nodes in Asian Patients with Lateral Lymph Node Dissection for Rectal Cancer: A Meta-analysis.

Authors:  Niki Christou; Jeremy Meyer; Christophe Combescure; Alexandre Balaphas; Joan Robert-Yap; Nicolas C Buchs; Frédéric Ris
Journal:  World J Surg       Date:  2021-02-04       Impact factor: 3.352

5.  Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis.

Authors:  Sicheng Zhou; Yujuan Jiang; Wei Pei; Jianwei Liang; Zhixiang Zhou
Journal:  BMC Surg       Date:  2021-12-28       Impact factor: 2.102

6.  Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis.

Authors:  Sicheng Zhou; Yujuan Jiang; Jianwei Liang; Qian Liu
Journal:  World J Surg Oncol       Date:  2022-03-29       Impact factor: 2.754

Review 7.  Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection.

Authors:  Francesco Crafa; Serafino Vanella; Onofrio A Catalano; Kelsey L Pomykala; Mario Baiamonte
Journal:  World J Gastroenterol       Date:  2022-08-14       Impact factor: 5.374

8.  Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series.

Authors:  Amine Souadka; Mohammed Anass Majbar; Amine Benkabbou; Badr Serji; Tarik Souiki; Sidi Mohammed Bouchentouf; Mourad Abid; Basma El Khannousi; Tijani El Harroudi; Hadj Omar El Malki; Mohammed Raiss; Lahsen Ifrine; Khalid Mazaz; Aziz Zentar; Raouf Mohsine; Abdelilah Souadka; Abdelkader Belkouchi; Mohammed Ahallat; Abdelmalek Hrora
Journal:  BMC Cancer       Date:  2019-10-28       Impact factor: 4.430

9.  Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.

Authors:  Sicheng Zhou; Yujuan Jiang; Wei Pei; Jianwei Liang; Zhixiang Zhou
Journal:  BMC Cancer       Date:  2022-02-03       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.